Medindia

X

ResMed Inc. Announces Record Financial Results for the Quarter and Twelve Months Ended June 30, 2010

Friday, August 6, 2010 Hospital News J E 4
Advertisement
*RESMED ALSO ANNOUNCES TWO-FOR-ONE STOCK SPLIT

RESMED INC AND SUBSIDIARIESConsolidated Balance Sheets (Unaudited)(In US$ thousands except share and per share data)

June 30,

June 30,

2010

2009

ASSETS

Current assets:

Cash and cash equivalents

$488,776

$415,650

Accounts receivable, net

226,911

212,096

Inventories

185,642

157,431

Deferred income taxes

40,227

44,368

Income taxes receivable

5,317

2,067

Prepaid expenses and other current assets

38,468

21,672

Total current assets

985,341

853,284

Property, plant and equipment, net

387,148

377,613

Goodwill

198,625

213,169

Other intangibles

30,925

35,023

Deferred income taxes

19,042

19,364

Other assets

5,316

9,515

Total non-current assets

641,056

654,684

Total assets

$1,626,397

$1,507,968

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

57,535

$48,293

Accrued expenses

80,883

67,018

Deferred revenue

29,507

28,881

Income taxes payable

22,656

56,972

Deferred income taxes

402

391

Current portion of long-term debt

94,161

67,545

Total current liabilities

285,144

269,100

Non-current liabilities:

Deferred income taxes

10,793

11,137

Deferred revenue

12,755

15,238

Income taxes payable

2,641

3,110

Long-term debt

27,528

94,191

Total non-current liabilities

53,717

123,676

Total liabilities

338,861

392,776

Stockholders' Equity:

Common stock

303

303

Additional paid-in capital

660,487

522,980

Retained earnings

884,876

694,791

Treasury stock

(344,505)

(208,659)

Accumulated other comprehensive income

86,375

105,777

Total stockholders' equity

1,287,536

1,115,192

Total liabilities and stockholders' equity

$1,626,397

$1,507,968

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
IRIDEX Reports Second Quarter 2010 Financial Resul...
S
Oncothyreon reports second quarter 2010 financial ...